Measles outbreak in south of Iran, where vaccine coverage was high: A case-series study

Iranian Journal of Public Health

Volumn 43, Issue 3, 2014, Pages 375-380

  Moghadami, Mohsen ^a   Afsarkazerooni, Parvin ^a   Ebrahimi, Mostafa ^a   Soltani, Mahboobe ^a   Razmpoor, Ardeshir ^a   Pirasteh, Esmaeil ^a   Mirah Madizadeh, Alireza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Iran; Measles; Outbreak; Vaccination

Indexed keywords

EID: 84898416516     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Moss WJ, Griffin DE (2012). Measles. Lancet, 379:153-64.
2. WHO (2013). Global Immunization Data. Available at http://www.who.int/immunization_monitor-ing/Global_Immunization_Data.pdf. Access date: 4-4-2013.
3. Murray CJL, Lopez AD (1997). Mortality case for eight regions of the world: global burden of dis-ease study. Lancet, 349:1269-76.
4. Fine PEM (1993). Herd immunity: history, theory, practice. Epidemiologic Reviews, 15:265-302.
5. Halsey NA (1983). The Optimal Age for Adminis-tering Measles Vaccine in Developing Countries. In: Halsey NA, de Quadros CA, editors. Recent Advances in Immunization. Washington, DC. PAHO, 4-13.
6. Van den Ent M, Gupta SK, Hoekstra E (2009). Two doses of measles vaccine reduce death. In-dian Pediatrics, 17: 933-38.
7. American Academy of Pediatrics, Committee on In-fectious Diseases (1989). Measles: Reassessment of the current immunization policy. Pediatrics, 84: 1110-13.
8. Cutts FT, Henao-Restrepo AM, Olive JM (1999). Measles elimination: progress and challenges. Vaccine, 17: S47-S52.
9. EPI (1996). Meeting on advances in measles elimi-nation: conclusions and recommendations. Week-ly Epidemiological Record, 71:305-12.
10. WHO (2012). Measles immunization coverage by country. Available at http://apps.who.int/gho/da-ta/view.main.230.Access date: 4-4-2013
11. Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F (2007). Progress in measles and rubella elimination in Iran. Pediatr In-fect Dis J, 26(12):1137-1141.
12. World Health Organization (1999). The World Health report, 1999-making a difference. Ge-neva: World Health Organization, 98:104.
13. Mulholland EK, Griffiths UK, Biellik R (2012). Measles in the 21stCentury. N Engl J Med, 366:1755-7.
14. World Health Organization (2011). Measles out-breaks and progress towards meeting measles pre-elimination goals: WHO African Region, 2009-2010. Wkly Epidemiol Rec, 86:129-40.
15. WHO (2013). Reported measles cases and incidence rates by WHO Member States 2012. Available at http://www.who.int/immunization_monitor-ing/diseases/measlesreportedcasesbycountry.pdf Access date: 4-4-2013.
16. Colinet G, Rossignol J, Peetermans J (1982). A study of the stability of a bivalent measles-mumps vac-cine. J Biol Stand, 10:341-346.
17. Galazka A, Milstien J, Zaffran M (1998). Thermosta-bility of vaccines. Geneva: World Health Organi-zation. (WHOdocumentWHO/GPV/98.07).
18. Moss WJ, Griffin DE (2006). Global measles elimi-nation. Nat Rev Microbiol, 4:900-908.
19. Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y (1998). Deficiency of the humoral immune response to measles vac-cine in infants immunized at age 6 months. J Am Med Assoc, 280(6):527-32.
20. Angel JB, Walpita P, Lerch RA, Sidhu MS, Ma-suredar M, DeLellis RA et al(1998).Vaccine-asso-ciated measles pneumonitis in an adult with AIDS. Ann Intern Med,129:104-6.
21. Mulholland K (1995). Measles and Pertussis in de-veloping countries with good vaccine coverage. Lancet, 345:305-7.
22. WHO (2009). Guidelines for epidemic preparedness and re-sponse to measles outbreaks Geneva: (WHO/IVB/09.03). Available from: http://whqlibdoc.who.int/hq/2009/who_ivb_09.03_eng.pdf. (Accessed on 7-4-2013).
23. Al Wahaibi S, El-Bushra HE, Al-Sulaiman MA (1997). Measles outbreak in Riyadh City, 1997. Saudi Epidemiology Bulletin, 4(2):4-5.
24. Zahraei SM, Gouya MM, Mokhtari Azad T, Soltanshahi R, et al (2011). Successful Control and Impending Elimination of Measles in the Is-lamic Republic of Iran. JID, 204:305-311.
25. Majdzadeh R, Moradi A, Zeraati H, Ghajari-ehSepanlou S, Zamani G, Zonobi V (2008). Evaluation of the measles-rubella mass vaccina-tion campaign in the population covered by Teh-ran University of Medical Sciences. East Mediterr Health J, 14:810-7.
26. Ministry of Health and Medical Education of IRI (1998).Study of measles epidemiology in Iran during 1991 to 1998. Annual report of the Minister of Health and Medical Education, Tehran.
27. Ministry of Health and Medical Education of IRI (2002).Health picture. Annual report of the Minister of Health and Medical Education, Tehran.
28. Izadi S, Zahraie SM, Sartipi M (2012). An Investiga-tion into a Measles Outbreak in Southeast Iran. Jpn J Infect Dis, 65:45-51.
29. Paunio M, Peltola H, Valle M, et al(1998). Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among re-vaccinees. Am J Epidemiol, 148: 1103.
30. Zenner D, Nacul L (2012).Predictive power of Koplik's spots for the diagnosis of measles. J Infect Dev Ctries, 6:271-5.
31. Clements C J (1994). Global programme for vac-cines of the World Health Organization. Role of mass campaigns in global measles control. Lancet, 344:174-5.